GPT‑Rosalind for life sciences research

GPT-Rosalind, a new OpenAI tool based on GPT-4 and fine-tuned on scientific data, has been launched to accelerate life sciences research. It addresses the data bottleneck by optimizing hypothesis generation, literature analysis, and experimental design, with the potential to reduce drug development costs and timelines.